The Europe Osteosynthesis Devices Market would witness market growth of 7.8% CAGR during the forecast period (2022-2028).
Arthroscopic-assisted between 3 and 7 days following the initial traumatic event, internal fixation can be carried out under either axillary block or general anesthesia. By waiting a few days, the surgeon can avoid visualization issues brought on by active bleeding.
Internal bone fixation devices that are absorbed by the body would prevent the need for a second surgery to remove them once the bone has healed. Additionally, because they wouldn't need to be as rigid as the metallic devices currently in use, they wouldn't contribute to osteoporosis. A method has been established to create polylactide with a low monomer content and a high molecular weight. Following simulated in vitro experiments and in vivo implants, chemical and mechanical tests were used to characterize this polymer. In rabbit and canine models, the polymer's biocompatibility has been demonstrated. The restoration of the canine radius and tibia models has demonstrated both the body absorption of the polylactide bone plates and screws in addition to their effectiveness.
Along with increased research and more current developments in bioabsorbable osteosynthesis implants, maxillofacial surgeons have recently given much more attention to bioabsorbable materials.
The presence of advanced healthcare infrastructure, modern products, and qualified expertise contributes to the growing demand for Osteosynthesis Devices across this region in the near future. Another important factor expected to promote regional market expansion is the growing demand for sophisticated therapies and products in Europe. In several European countries, the geriatric population is quickly growing.
The Germany market dominated the Europe Osteosynthesis Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $952.7 million by 2028, growing at a CAGR of 6.5 % during the forecast period. The UK market is registering a CAGR of 6.9% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 8.6% during (2022 - 2028).
Based on Type, the market is segmented into Internal (Screws & Plates, Wires & Pins, Intramedullary Rods & Nails, and Spinal Fixation Devices) and External (Fracture Fixation and Bone Lengthening). Based on Material, the market is segmented into Nondegradable and Degradable. Based on Fracture Type, the market is segmented into Patella, Tibia or Fibula, or Ankle, Hand & Wrist, Foot Bones & Vertebral Column, Hip, Pelvis, Clavicle, Scapula, or Humerus, Femur, Radius or ulna, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Osteosynthesis Devices Market will Hit $14.2 Billion by 2028, at a CAGR of 8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include DePuy Synthes, Inc. (J & J Company), Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew PLC, Medtronic PLC, Olympus Corporation, Globus Medical, Inc., Arthrex, Inc., Lepu Medical Technology Co., Ltd, and Life Spine, Inc.
By Type
By Material
By Fracture Type
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 